Abstract
Fullerenes are a new carbonic allotrope having a cage structure. We investigated whether fullerenes containing one or two atoms of heavy metals could be an X-ray contrast material with little adverse effects. One or two atoms of dysprosium (Dy), erbium (Er), gadolinium (Gd), europium (Eu) and lutetium (Lu) were encapsulated into fullerene (C82), which was synthesized as a polyhydroxyl form (e.g., Gd@C82(OH)n, n=40, Gd – fullerenols). They were dissolved in water at maximum soluble concentrations and subjected to CT number analysis. The CT numbers of the solutions were measured using a 4- or 16-row multidetector CT scanner. The CT number of the water-soluble metallofullerenes were 56.0 HU for Dy@C82(OH)40, 111.5 HU for Er@C82(OH)40, 58.4 HU for Gd@C82(OH)40, 100.9 HU for Eu@C82(OH)40 and 23.3 HU for Lu2@C82(OH)40. The CT numbers of the metallofullerenes investigated in the present study were not high enough to be used in the clinic in place of iodinated contrast materials. However, if nanotechnology progresses in the near future, it may prove to have a possibility as an X-ray contrast material.
Similar content being viewed by others
References
Morcos SK, Thomsen HS, Webb JAW and ESUR Contrast Media Safety Committee (1999) Contrast media-induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613. DOI 10.1007/s003300050894
Thomsen HS, Morcos SK and Members of Contrast Media Safety Committee of ESUR (2005) In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15:749–754. DOI 10.1007/s00330-004-2591-y
Van der Molen AJ, Thomsen HS, Morcos SK, ESUR Contrast Media Safety Committee (2004) Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 14:902–907. DOI 10.1007/s00330-004-2238-z
Morcos SK, Thomsen HS, Exley CM and Members of Contrast Media Safety Committee of ESUR (2005) Contrast media: interactions with other drugs and clinical tests. Eur Radiol 15:1463–1468. DOI 10.1007/s00330-004-2600-1
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621–628
Petersein J, Peters CR, Wolf M, Hamm B (2003) Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 13:2006–2011. DOI 10.1007/s00330-002-1583-z
Shinohara H (2000) Endohedral metallofullerenes. Rep Prog Phys 63:843–892
Shi Z, Okazaki T, Shimada T, Sugai T, Suenaga T, Shinohara H (2003) Selective high-yield catalytic synthesis of terbium metallofullerenes and single-wall carbon nanotubes. J Phys Chem B 107:2485–2489
Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N, Shinohara H (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem 12:510–514. DOI 10.1021/bc000136m
Osawa E (1970) Chohokozoku. Kagaku 25:854–863 (in Japanese)
Kroto HW, Heath JR, O’Brien SC, Curl RF, Smalley RF (1985) C60: Buckminsterfullerene. Nature 318:162–163. DOI 10.1038/318162a0
Krätschmer W, Fostiropoulos K, Lamb LD, Hufmman DR (1990) Solid C60: a new form of carbon. Nature 347:354–358. DOI 10.1038/347354a0
Krätschmer W, Fostiropoulos K, Hufmman DR (1990) The infrared and ultraviolet absorption spectra of laboratory-produced carbon dust: evidence for the presence of the C60 molecule. Chem Phys Lett 170:167–170
Takata M, Umeda B, Nishibori E, Sakata M, Saito Y, Ohno M, Shinohara H (1995) Confirmation by X-ray diffraction of the endohedral nature of the metallofullerene Y@C82. Nature 377:46–49. DOI 10.1038/377046a0
Tagmatarchis N, Shinohara H (2001) Fullerenes in medical chemistry and their biological applications. Mini Rev Med Chem 1:339–348
Yamago S, Tokuyama H, Nakamura E, Kikuchi K, Kananishi S, Sueki K, Nakahara H, Enomoto S, Ambe F (1995) In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2:385–389
Kato H, Kanazawa Y, Okumura M, Taninaka A, Yokawa T, Shinohara H (2003) Lanthanoid endohedral metallofullerenols for MRI contrast agents. J Am Chem Soc 125:4391–4397. DOI 10.1021/ja027555+
Kato H, Yashiro A, Mizuno A, Nishida Y, Kobayashi K, Shinohara H (2001) Syntheses and biological evaluations of α-D-mannosyl[60]fullerenols. Bioorg Med Chem Lett 11:2935–2939
Simon HF, Dianne LD, Rint PS, Gordana S, Fred W, George LK (1993) Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc 115:6506–6509
Nakamura E, Isobe H, Tomita N, Sawamura M, Jinno S, Okayama H (2000) Functionalized fullerene as an artificial vector for transfection. Angew Chem Int Ed 39:4254–4257
Isobe H, Sugiyama S, Fukui K, Iwasawa Y, Nakamura E (2001) Atomic force microscope studies on condensation of plasmid DNA with functionalized fullerenes. Angew Chem Int Ed 40:3364–3367
Acknowledgement
This work was supported in part by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyamoto, A., Okimoto, H., Shinohara, H. et al. Development of water-soluble metallofullerenes as X-ray contrast media. Eur Radiol 16, 1050–1053 (2006). https://doi.org/10.1007/s00330-005-0064-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-005-0064-6